FDAnews Device Daily Bulletin

J&J Q3 Earnings Dip on Manufacturing Issues

Dec. 9, 2011
A A
Diversion of resources from marketing and research to quality and manufacturing figured into a domestic sales slump and a 6 percent drop in earnings at Johnson & Johnson (J&J) in the third quarter from the same period in 2010.
The GMP Letter